• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 3. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 4. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 5. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidolactams Imidolactams
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidolactams

1-3-(Propan-2-yloxy)propyl-1H-pyrazol-3-amine: A Comprehensive Overview

The compound with CAS No. 1339422-72-8, commonly referred to as 1-3-(propan-2-yloxy)propyl-1H-pyrazol-3-amine, is a fascinating molecule that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the class of pyrazole derivatives, which are known for their diverse biological activities and potential applications in drug discovery. The structure of 1H-pyrazol is central to its functionality, with the substituent propan-2-yloxypropyl playing a crucial role in modulating its chemical and biological properties.

Recent studies have highlighted the importance of pyrazole derivatives in medicinal chemistry due to their ability to interact with various biological targets. For instance, research published in 2023 demonstrated that 1H-pyrazol derivatives can act as potent inhibitors of certain kinases, making them promising candidates for anti-cancer therapies. The presence of the propan-2-yloxypropyl group in this compound further enhances its bioavailability and stability, which are critical factors for drug development.

The synthesis of 1-3-(propan-2-yloxy)propyl-1H-pyrazol-3-amine involves a multi-step process that typically begins with the preparation of the pyrazole ring. This is followed by the introduction of the propan-2-yloxypropyl group through nucleophilic substitution or coupling reactions. Advanced techniques such as microwave-assisted synthesis and catalytic methods have been employed to optimize the reaction conditions, ensuring high yields and purity.

In terms of applications, this compound has shown potential in several therapeutic areas. For example, it has been investigated for its anti-inflammatory properties, with studies indicating that it can effectively inhibit COX enzymes, which are key players in inflammation. Additionally, preliminary results suggest that this compound may possess antioxidant activity, making it a candidate for neuroprotective agents.

One of the most exciting developments involving this compound is its role in targeted drug delivery systems. Researchers have explored the use of pyrazole derivatives as carriers for delivering therapeutic agents to specific tissues or cells. The unique structure of 1H-pyrazol allows for functionalization with targeting ligands, enhancing the specificity and efficacy of drug delivery.

From a structural perspective, the propan-2-yloxypropyl group introduces steric hindrance and hydrophilic properties to the molecule. These characteristics not only influence its solubility but also play a significant role in its interactions with biological membranes. Computational studies using molecular docking have provided insights into how this compound binds to various receptors, further elucidating its mechanism of action.

Looking ahead, ongoing research aims to explore the pharmacokinetic profile of 1-3-(propan-2-yloxy)propyl-1H-pyrazol-3-amine in preclinical models. Understanding its absorption, distribution, metabolism, and excretion (ADME) properties will be essential for advancing it into clinical trials. Furthermore, efforts are being made to identify additional biological targets that this compound can modulate, broadening its potential therapeutic applications.

In conclusion, 1H-pyrazol derivatives like 1-3-(propan-2-yloxy)propyl-1H-pyrazol-3-amine represent a promising class of compounds with diverse biological activities and therapeutic potential. As research continues to uncover new insights into their structure-function relationships and mechanisms of action, they are likely to play an increasingly important role in drug discovery and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)